215 related articles for article (PubMed ID: 15748431)
1. [Complications of successively double autologous hemopoietic stem cell transplants].
Huang WR; Da WM; Zhang BL; Gao CJ; Han XP; Jing Y; Wu XX; Zhao Y; Li HH; Wang QS; Zhang YZ; Bo J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):30-4. PubMed ID: 15748431
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of double autologous hemopoietic stem cell transplantation for hematological malignancies].
Zhang B; Huang W; Da W; Zhang Z; Yao S; Gao C; Han X; Wu X; Wang Q; Yu L; Zhang M; Jin H
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):123-6. PubMed ID: 11953143
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic stem cell transplantation for hematological malignancies].
Zhong MZ; Chen FP; Shu YG
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):242-4. PubMed ID: 12575304
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of rhG-CSF in accelerating hematological recovery following autologous hematopoietic stem cells transplantation].
Yang JL; Shi YK; He XH; Zhou SY; Zhou AP; Han XH; Liu P; Zhang CG; Ai B
Ai Zheng; 2003 Aug; 22(8):785-9. PubMed ID: 12917020
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
[TBL] [Abstract][Full Text] [Related]
7. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
[TBL] [Abstract][Full Text] [Related]
8. Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.
Konuma T; Kato S; Ooi J; Oiwa-Monna M; Kawamata T; Tojo A; Takahashi S
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1150-5. PubMed ID: 24727335
[TBL] [Abstract][Full Text] [Related]
9. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
11. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of double autologous hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia].
Huang W; Zhang B; Yao S
Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):399-402. PubMed ID: 11718088
[TBL] [Abstract][Full Text] [Related]
13. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
Wang H; Cui X; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783
[TBL] [Abstract][Full Text] [Related]
14. Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.
Bay JO; Cabrespine A; Faucher C; Tabrizi R; Bordigoni P; Berceanu A; Coiteux V; Renaud M; Mialou V; Robin M; Kuentz M; Chevallier P; Dhédin N; Huynh A; Garban F; Witz F; Buzyn A; De Revel T; Galambrun C; Deconinck E; Contentin N; François S; Gratecos N; Blaise D; Michallet M;
Biol Blood Marrow Transplant; 2012 Feb; 18(2):250-6. PubMed ID: 21745455
[TBL] [Abstract][Full Text] [Related]
15. Circulating hematopoietic progenitor cells after autologous stem cell transplant for hematological malignancies.
Piccirillo N; De Matteis S; Ausoni G; Laurenti L; Tarnani M; Chiusolo P; Fancello G; Rumi G; Sorà F; D'onofrio G; Leone G; Sica S
Leuk Lymphoma; 2010 Jun; 51(6):1135-8. PubMed ID: 20367568
[No Abstract] [Full Text] [Related]
16. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
17. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Influence of Different Comorbidities Indexes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in a Developing Country.
Teixeira GM; Bittencourt H; de Macedo AV; Martinho GH; Colosimo EA; Rezende SM
PLoS One; 2015; 10(9):e0137390. PubMed ID: 26394228
[TBL] [Abstract][Full Text] [Related]
19. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution.
Rogulj D; Batinić D; Nemet D; Petrovecki M
Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
